Pharmacogenomics (PGx) Market Report

Global and Region Pharmacogenomics (PGx) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：226
  • REPORT CODE：GMM903177
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs.

    The report details the trend, potential and market size of Pharmacogenomics (PGx) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Pharmacogenomics (PGx)market, defines the market attractiveness level of Pharmacogenomics (PGx) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Pharmacogenomics (PGx) industry, describes the types of Pharmacogenomics (PGx) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pharmacogenomics (PGx) market and the development prospects and opportunities of Pharmacogenomics (PGx) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pharmacogenomics (PGx) market in Chapter 13.

    By Player:

    • Illumina, Inc

    • Pathway Genomics

    • Abbott Laboratories

    • 23andMe, Inc

    • GeneTech

    • GeneDx

    • Thermo Fisher Scientific

    • Genset

    • Pfizer, Inc

    • Transgenomic, Inc

    • Affymetrix, Inc

    By Type:

    • Polymerase Chain Reaction (PCR)

    • Microarray

    • Sequencing

    • Other

    By End-User:

    • Cardiovascular Diseases (CVD)

    • Central Nervous System (CNS)

    • Cancer/Oncology

    • Infectious Diseases

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Pharmacogenomics (PGx) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Pharmacogenomics (PGx) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Pharmacogenomics (PGx) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Pharmacogenomics (PGx) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Pharmacogenomics (PGx) Market Analysis and Outlook to 2022

    • 7.1 Global Pharmacogenomics (PGx) Consumption (2017-2022)

    • 7.2 United States Pharmacogenomics (PGx) Consumption (2017-2022)

    • 7.3 Europe Pharmacogenomics (PGx) Consumption (2017-2022)

    • 7.4 China Pharmacogenomics (PGx) Consumption (2017-2022)

    • 7.5 Japan Pharmacogenomics (PGx) Consumption (2017-2022)

    • 7.6 India Pharmacogenomics (PGx) Consumption (2017-2022)

    • 7.7 South Korea Pharmacogenomics (PGx) Consumption (2017-2022)

    8 Region and Country-wise Pharmacogenomics (PGx) Market Analysis and Outlook to 2028

    • 8.1 Global Pharmacogenomics (PGx) Consumption Forecast (2022-2028)

    • 8.2 United States Pharmacogenomics (PGx) Consumption Forecast (2022-2028)

    • 8.3 Europe Pharmacogenomics (PGx) Consumption Forecast (2022-2028)

    • 8.4 China Pharmacogenomics (PGx) Consumption Forecast (2022-2028)

    • 8.5 Japan Pharmacogenomics (PGx) Consumption Forecast (2022-2028)

    • 8.6 India Pharmacogenomics (PGx) Consumption Forecast (2022-2028)

    • 8.7 South Korea Pharmacogenomics (PGx) Consumption Forecast (2022-2028)

    9 Global Pharmacogenomics (PGx) Market Outlook by Types and Applications to 2022

    • 9.1 Global Pharmacogenomics (PGx) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Polymerase Chain Reaction (PCR) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Microarray Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Sequencing Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pharmacogenomics (PGx) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cardiovascular Diseases (CVD) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Central Nervous System (CNS) Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cancer/Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Infectious Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Pharmacogenomics (PGx) Market Outlook by Types and Applications to 2028

    • 10.1 Global Pharmacogenomics (PGx) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Polymerase Chain Reaction (PCR) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Microarray Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Sequencing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Pharmacogenomics (PGx) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cardiovascular Diseases (CVD) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Central Nervous System (CNS) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cancer/Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Pharmacogenomics (PGx) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Pharmacogenomics (PGx) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Pharmacogenomics (PGx) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Pharmacogenomics (PGx) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Pharmacogenomics (PGx) Market Competitive Analysis

    • 14.1 Illumina, Inc

      • 14.1.1 Illumina, Inc Company Details

      • 14.1.2 Illumina, Inc Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Illumina, Inc Pharmacogenomics (PGx) Product and Service

    • 14.2 Pathway Genomics

      • 14.2.1 Pathway Genomics Company Details

      • 14.2.2 Pathway Genomics Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pathway Genomics Pharmacogenomics (PGx) Product and Service

    • 14.3 Abbott Laboratories

      • 14.3.1 Abbott Laboratories Company Details

      • 14.3.2 Abbott Laboratories Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Abbott Laboratories Pharmacogenomics (PGx) Product and Service

    • 14.4 23andMe, Inc

      • 14.4.1 23andMe, Inc Company Details

      • 14.4.2 23andMe, Inc Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 23andMe, Inc Pharmacogenomics (PGx) Product and Service

    • 14.5 GeneTech

      • 14.5.1 GeneTech Company Details

      • 14.5.2 GeneTech Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GeneTech Pharmacogenomics (PGx) Product and Service

    • 14.6 GeneDx

      • 14.6.1 GeneDx Company Details

      • 14.6.2 GeneDx Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 GeneDx Pharmacogenomics (PGx) Product and Service

    • 14.7 Thermo Fisher Scientific

      • 14.7.1 Thermo Fisher Scientific Company Details

      • 14.7.2 Thermo Fisher Scientific Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Product and Service

    • 14.8 Genset

      • 14.8.1 Genset Company Details

      • 14.8.2 Genset Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Genset Pharmacogenomics (PGx) Product and Service

    • 14.9 Pfizer, Inc

      • 14.9.1 Pfizer, Inc Company Details

      • 14.9.2 Pfizer, Inc Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer, Inc Pharmacogenomics (PGx) Product and Service

    • 14.10 Transgenomic, Inc

      • 14.10.1 Transgenomic, Inc Company Details

      • 14.10.2 Transgenomic, Inc Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Transgenomic, Inc Pharmacogenomics (PGx) Product and Service

    • 14.11 Affymetrix, Inc

      • 14.11.1 Affymetrix, Inc Company Details

      • 14.11.2 Affymetrix, Inc Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Affymetrix, Inc Pharmacogenomics (PGx) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Pharmacogenomics (PGx)

    • Figure Pharmacogenomics (PGx) Picture

    • Table Global Pharmacogenomics (PGx) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pharmacogenomics (PGx) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pharmacogenomics (PGx) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Pharmacogenomics (PGx) Consumption by Country (2017-2022)

    • Figure United States Pharmacogenomics (PGx) Consumption and Growth Rate (2017-2022)

    • Table Europe Pharmacogenomics (PGx) Consumption and Growth Rate (2017-2022)

    • Figure China Pharmacogenomics (PGx) Consumption and Growth Rate (2017-2022)

    • Figure Japan Pharmacogenomics (PGx) Consumption and Growth Rate (2017-2022)

    • Figure India Pharmacogenomics (PGx) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pharmacogenomics (PGx) Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacogenomics (PGx) Consumption Forecast by Country (2022-2028)

    • Figure United States Pharmacogenomics (PGx) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pharmacogenomics (PGx) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Pharmacogenomics (PGx) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pharmacogenomics (PGx) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pharmacogenomics (PGx) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pharmacogenomics (PGx) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Polymerase Chain Reaction (PCR) Consumption and Growth Rate (2017-2022)

    • Figure Global Microarray Consumption and Growth Rate (2017-2022)

    • Figure Global Sequencing Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Diseases (CVD) Consumption and Growth Rate (2017-2022)

    • Figure Global Central Nervous System (CNS) Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer/Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Polymerase Chain Reaction (PCR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microarray Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Diseases (CVD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Central Nervous System (CNS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer/Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Pharmacogenomics (PGx) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Pharmacogenomics (PGx) Export by Region (Top 5 Countries) (2017-2028)

    • Table Illumina, Inc (Foundation Year, Company Profile and etc.)

    • Table Illumina, Inc Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina, Inc Pharmacogenomics (PGx) Product and Service

    • Table Pathway Genomics (Foundation Year, Company Profile and etc.)

    • Table Pathway Genomics Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pathway Genomics Pharmacogenomics (PGx) Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Pharmacogenomics (PGx) Product and Service

    • Table 23andMe, Inc (Foundation Year, Company Profile and etc.)

    • Table 23andMe, Inc Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table 23andMe, Inc Pharmacogenomics (PGx) Product and Service

    • Table GeneTech (Foundation Year, Company Profile and etc.)

    • Table GeneTech Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GeneTech Pharmacogenomics (PGx) Product and Service

    • Table GeneDx (Foundation Year, Company Profile and etc.)

    • Table GeneDx Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GeneDx Pharmacogenomics (PGx) Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Pharmacogenomics (PGx) Product and Service

    • Table Genset (Foundation Year, Company Profile and etc.)

    • Table Genset Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genset Pharmacogenomics (PGx) Product and Service

    • Table Pfizer, Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer, Inc Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer, Inc Pharmacogenomics (PGx) Product and Service

    • Table Transgenomic, Inc (Foundation Year, Company Profile and etc.)

    • Table Transgenomic, Inc Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Transgenomic, Inc Pharmacogenomics (PGx) Product and Service

    • Table Affymetrix, Inc (Foundation Year, Company Profile and etc.)

    • Table Affymetrix, Inc Pharmacogenomics (PGx) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Affymetrix, Inc Pharmacogenomics (PGx) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US